Department of Gastroenterology, Second Affiliated Hospital of Harbin Medical University, No, 246 Xuefu Road, Nangang, Harbin 150086, People's Republic of China.
World J Surg Oncol. 2013 Oct 12;11:271. doi: 10.1186/1477-7819-11-271.
The impact of body mass index (BMI) on the prognosis of patients with colorectal cancer remains largely unknown, particularly in Asian populations. Therefore, the aim of this study was to examine the influence of BMI on clinicopathological characteristics and mortality of Chinese colorectal cancer patients.
The study cohort consisted of 525 patients who were diagnosed with colorectal cancer and underwent radical surgery at the second hospital of Harbin Medical University between June 2004 and August 2011. Study participants were divided into two BMI categories: normal weight (BMI <23 kg/m²) and overweight (BMI ≥23 kg/m²).
Of 525 patients, 208 patients (39.6%) were included in the normal-weight group and 317 patients were included in the overweight group. During the mean follow-up period of 48.8 months, 89 patients had disease recurrence and 131 deaths occurred. High BMI was significantly correlated with younger age, presence of diabetes, alcohol consumption, distal colon tumors, amount of lymph node harvested and pathological stage. No statistically significant correlation was found between high BMI and progression-free survival (PFS) or overall survival (OS) when the total group of patients was considered (P = 0.077 and P = 0.701, respectively). Cigarette-smoking patients had significantly shorter OS than patients who had never smoked (hazard ratio = 1.613, 95% confidence interval = 1.133 to 2.296; P = 0.008), and this difference in OS remained significant in multivariate analysis. Cigarette-smoking patients did not have significantly different PFS compared with patients who had never smoked.
There was no significant correlation between obesity and outcomes of patients with colorectal cancer. In addition, our findings support the claims that cigarette smoking may be partially responsible for the divergent mortality of patients with colorectal cancer.
体重指数(BMI)对结直肠癌患者预后的影响在很大程度上尚不清楚,特别是在亚洲人群中。因此,本研究旨在探讨 BMI 对中国结直肠癌患者临床病理特征和死亡率的影响。
研究队列包括 525 名在哈尔滨医科大学第二医院接受根治性手术的结直肠癌患者,入组时间为 2004 年 6 月至 2011 年 8 月。研究参与者被分为两个 BMI 类别:正常体重(BMI<23kg/m²)和超重(BMI≥23kg/m²)。
在 525 名患者中,208 名(39.6%)患者被归入正常体重组,317 名患者被归入超重组。在平均随访 48.8 个月期间,89 名患者出现疾病复发,131 名患者死亡。高 BMI 与年龄较小、糖尿病、饮酒、远端结肠肿瘤、淋巴结清扫量和病理分期显著相关。当考虑所有患者时,高 BMI 与无进展生存期(PFS)或总生存期(OS)之间没有统计学意义上的相关性(P=0.077 和 P=0.701)。与从不吸烟的患者相比,吸烟的患者 OS 明显更短(风险比=1.613,95%置信区间=1.133 至 2.296;P=0.008),且在多变量分析中这一 OS 差异仍然显著。吸烟的患者与从不吸烟的患者相比,PFS 没有显著差异。
肥胖与结直肠癌患者的预后之间没有显著相关性。此外,我们的研究结果支持吸烟可能部分导致结直肠癌患者死亡率差异的说法。